KELI Therapeutics is a clinical-stage biotech university spin-out company specializing in cell-based therapeutics. Seeking Visionary Investors: We are currently raising 5 Mio EUR (24 months of the runway) to accelerate our lead program, KELI-101, in a First-In-Human, multi-center, adaptive Ph1/2A-B clinical trial (24 months) Pioneering Allogeneic GMP-grade Placental Stem Cells: Backed by non-dilutive funding, our proprietary platform has undergone rigorous validation in four non-clinical animal studies, setting new benchmarks for therapeutic potential. 🧪 Expert Team of Biotech Innovators:…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$1M to $5M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.